ES2057159T3 - Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos. - Google Patents

Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos.

Info

Publication number
ES2057159T3
ES2057159T3 ES89400956T ES89400956T ES2057159T3 ES 2057159 T3 ES2057159 T3 ES 2057159T3 ES 89400956 T ES89400956 T ES 89400956T ES 89400956 T ES89400956 T ES 89400956T ES 2057159 T3 ES2057159 T3 ES 2057159T3
Authority
ES
Spain
Prior art keywords
compounds
stereo
preparation
therapeutic compositions
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89400956T
Other languages
English (en)
Inventor
Marc Bonato
Charles Eck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of ES2057159T3 publication Critical patent/ES2057159T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PROCEDIMIENTOS ESTEREOESPECIFICOS PARA LA PREPARACION DE ENANCIOMEROS DE LA FURO (3,4 - C) PIRIDINA SUSTITUIDA EN POSICION 3, DE FORMULA I, EN LA QUE R3, R4 Y R6 REPRESENTAN DIVERSOS SUSTITUYENTES, COMPRENDIENDO LAS ETAPAS SIGUIENTES: OXIDACION DE UN DERIVADO RACEMICO DE LA PIRIDINA DE FORMULA II, DESPUES REDUCCION DE LA CETONA OBTENIDA POR UN AGENTE REDUCTOR, CERRADURA O BLOQUEO ESTEREOESPECIFICO DEL GRUPO OH DEL ALCOHOL ENANCIOMERO APERTURA DEL CICLO ACETONIDO Y CICLIZACION DEL COMPUESTO OBTENIDO. LA PRESENTE INVENCION SE REFIERE IGUALMENTE A LOS COMPUESTOS ASI OBTENIDOS, Y A LAS COMPOSICIONES TERAPEUTICAS A BASE DE ESTOS COMPUESTOS.
ES89400956T 1988-04-06 1989-04-06 Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos. Expired - Lifetime ES2057159T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives

Publications (1)

Publication Number Publication Date
ES2057159T3 true ES2057159T3 (es) 1994-10-16

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89400956T Expired - Lifetime ES2057159T3 (es) 1988-04-06 1989-04-06 Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos.

Country Status (28)

Country Link
US (1) US5026855A (es)
EP (1) EP0337858B1 (es)
JP (1) JP2680456B2 (es)
KR (1) KR970005308B1 (es)
AT (1) AT397093B (es)
AU (1) AU616753B2 (es)
BE (1) BE1003843A4 (es)
CA (1) CA1338475C (es)
CH (1) CH680000A5 (es)
DK (1) DK167020B1 (es)
DZ (1) DZ1335A1 (es)
ES (1) ES2057159T3 (es)
FI (1) FI93116C (es)
FR (2) FR2629821B1 (es)
GB (2) GB8808001D0 (es)
IE (1) IE61915B1 (es)
IN (1) IN172987B (es)
MA (1) MA21529A1 (es)
MY (1) MY104424A (es)
NL (1) NL8920307A (es)
NZ (1) NZ228614A (es)
OA (1) OA09247A (es)
PT (1) PT90210B (es)
SE (1) SE509130C2 (es)
SG (1) SG40492G (es)
TN (1) TNSN89043A1 (es)
WO (1) WO1989009772A1 (es)
ZA (1) ZA892477B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (es) * 1981-02-10 1985-11-09 Scras
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
IN160104B (es) * 1983-04-05 1987-06-27 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
CH680000A5 (es) 1992-05-29
MY104424A (en) 1994-03-31
AU3419089A (en) 1989-11-03
FI93116B (fi) 1994-11-15
JPH02504394A (ja) 1990-12-13
JP2680456B2 (ja) 1997-11-19
GB8927509D0 (en) 1990-06-13
MA21529A1 (fr) 1989-12-31
SE509130C2 (sv) 1998-12-07
ATA900589A (de) 1993-06-15
KR900700483A (ko) 1990-08-13
SG40492G (en) 1992-06-12
BE1003843A4 (fr) 1992-06-30
US5026855A (en) 1991-06-25
EP0337858B1 (fr) 1994-06-08
DK611689A (da) 1989-12-05
FR2629820B1 (fr) 1993-12-03
OA09247A (fr) 1992-06-30
FR2629821A1 (fr) 1989-10-13
EP0337858A1 (fr) 1989-10-18
IN172987B (es) 1994-01-15
PT90210A (pt) 1989-11-10
ZA892477B (en) 1989-12-27
PT90210B (pt) 1994-06-30
FI895826A0 (fi) 1989-12-05
SE8904104D0 (sv) 1989-12-05
IE891076L (en) 1989-10-06
SE8904104L (sv) 1989-12-05
AT397093B (de) 1994-01-25
FI93116C (fi) 1995-02-27
WO1989009772A1 (fr) 1989-10-19
AU616753B2 (en) 1991-11-07
IE61915B1 (en) 1994-11-30
GB2235194B (en) 1992-01-29
GB2235194A (en) 1991-02-27
DZ1335A1 (fr) 2004-09-13
DK167020B1 (da) 1993-08-16
CA1338475C (en) 1996-07-23
NZ228614A (en) 1990-11-27
FR2629820A1 (fr) 1989-10-13
KR970005308B1 (ko) 1997-04-15
NL8920307A (nl) 1990-03-01
DK611689D0 (da) 1989-12-05
FR2629821B1 (fr) 1993-12-03
TNSN89043A1 (fr) 1991-02-04
GB8808001D0 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
ES2057159T3 (es) Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
DE2963183D1 (en) 1,4-dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions
DE3482039D1 (de) Benzofurancarboxamide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen die sie enthalten.
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
ES2145733T3 (es) Pteridinonas triciclicas y un procedimiento para su preparacion.
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2028865T3 (es) Procedimiento mejorado para la preparacion de derivados de macrolidas.
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ATE144983T1 (de) Neue tricyclische verbindung oder salze davon, verfahren zur herstellung und antimikrobieller wirkstoff, der sie enthält
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
SE8305390D0 (sv) Seskviterpenderivat
ES2053605T3 (es) Derivados de la tilosina y de la 10,11,12,13-tetrahidrotilosina, su metodo de preparacion y su utilizacion en composiciones farmaceuticas y en la preparacion de estas.
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
SE7703083L (sv) Forfarande for framstellning av piperidinderivat
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
MX9306394A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES520693A0 (es) Un procedimiento para la preparacion de derivados de fenilpiperazina.
ES2173316T3 (es) Derivados de galantamina y proceso para su preparacion.
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
DK582083A (da) 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater
DK287980A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
ES2138100T3 (es) Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 337858

Country of ref document: ES